1. Home
  2. CYTO

CYTO

Altamira Therapeutics Ltd.

Logo Altamira Therapeutics Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Founded: 2003 Country:
Bermuda
Bermuda
Employees: N/A City: N/A
Market Cap: 3.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 1.2M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -8.63 EPS Growth: N/A
52 Week Low/High: $1.61 - $29.00 Next Earning Date: 04-10-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: